| Trial Identifier: | D5084C00009 |
| Sponsor: | AstraZeneca |
| Start Date: | September 2020 |
| Primary Completion Date: | December 2022 |
| Study Completion Date: | March 2026 |
| Condition: | Lung Cancer |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| English Version | |
| Spanish (Argentina) Translation | |
| Hindi Translation | |
| Thai Translation | |
| Vietnamese Translation | |
| Taiwan (Traditional Chinese) Translation |
| Country | Location |
|---|---|
| AR | Buenos Aires, AR, C1120AAT |
| IN | Delhi, IN, 110085 |
| IN | Mumbai, IN, 400053 |
| TH | Bangkok, TH, 10330 |
| TH | Bangkok, TH, 10400 |
| TH | Bangkok, TH, 10700 |
| TH | Bangkok, TH, 10300 |
| TH | Bangkok, TH, 10210 |
| TH | Hat Yai, TH, 90110 |
| TH | Khon Kaen, TH, 40002 |
| TH | Muang, TH, 50200 |
| TW | Taichung City, TW, 402 |
| TW | Taipei, TW, 235 |
| TW | Taipei, TW, 11217 |
| TW | Taipei, TW, 100 |
| TW | Taoyuan City, TW, 333 |
| US, CA | Duarte, CA, US, 91010 |
| US, CA | Sacramento, CA, US, 95817 |
| VN | Ha Noi, VN, 100000 |
| VN | Hanoi, VN, 100000 |
| VN | Ho Chi Minh city, VN, 700000 |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company